Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> Dx: assess severity based on hx/PE (viral URI prodrome, rhinorrhea, cough, tachypnea, wheezing, rales, grunting, nasal flaring, apnea) [B/S]. Assess resp rate, retractions, O2 sat, and risk factors for severe dz: age <12 wks, prematurity, cardiopulmonary dz, in utero smoke exposure, immunodeficiency, congenital anomalies [B/M]. X-ray, lab studies not routinely recommended [B/M]; exception: test for RSV in hospitalized infants on palivizumab to determine breakthrough infxn; CXR for unexpected worsening, ICU admission, suspected airway complication (eg, pneumothorax). <br><br>
<sup>2</sup> Exclusions: Children w/ acidosis or fever.
<br><br>
<sup>3</sup> Use of pulse oximetry may prolong hospitalization.
<br><br>
<sup>4</sup> AAP no longer recommends trial of albuterol, as in 2006 guideline.
<br><br>
<sup>5</sup> Suctioning of the nares may be beneficial, but not routine deep suctioning.
<br><br>
<sup>6</sup> Do not administer antibiotics unless concomitant bacterial infxn present/strongly suspected [B/S]. Refer to AAP AOM guidelines if otitis media suspected.
<sup>2</sup> Exclusions: Children w/ acidosis or fever.
<br><br>
<sup>3</sup> Use of pulse oximetry may prolong hospitalization.
<br><br>
<sup>4</sup> AAP no longer recommends trial of albuterol, as in 2006 guideline.
<br><br>
<sup>5</sup> Suctioning of the nares may be beneficial, but not routine deep suctioning.
<br><br>
<sup>6</sup> Do not administer antibiotics unless concomitant bacterial infxn present/strongly suspected [B/S]. Refer to AAP AOM guidelines if otitis media suspected.
Detail Type
Text
Detail Text